Redmile Group, LLC

13F Portfolio Filings

Most recent 13F
Q3 2026
Location
Larkspur, CA
CIK
0001425738
All SEC filings
View on sec.gov
Holdings Value, Excluding Options
Quarter Holdings Value, Excl. Options ($000) Top Holdings Form Type Date Filed Filing ID
Q3 2026 44 1,366,252 NRIX, KRYS, SRRK, STOK 13F-HR 11/16/2026 000090514826004923
Q2 2026 39 1,489,509 SRRK, KRYS, STOK, IMNM 13F-HR 8/14/2026 000110465926097182
Q1 2026 35 1,510,149 SRRK, KRYS, STOK, IMNM 13F-HR 5/15/2026 000110465926062579
Q4 2025 34 1,357,911 SRRK, KRYS, NRIX, STOK 13F-HR 2/17/2026 000110465926016433
Q3 2025 40 1,027,816 SRRK, KRYS, STOK, ZYME 13F-HR 11/14/2025 000110465925112572
Q2 2025 48 939,575 SRRK, KRYS, ZYME, STOK 13F-HR 8/14/2025 000110465925078608
Q1 2025 56 1,057,998 SRRK, KRYS, FOLD, ZYME 13F-HR 5/15/2025 000110465925049578
Q4 2024 62 1,434,861 SRRK, KRYS, NRIX, ZYME 13F-HR 2/14/2025 000110465925014154
Q3 2024 63 1,697,433 KRYS, NRIX, FOLD, IMNM 13F-HR 11/14/2024 000110465924118934
Q2 2024 63 1,653,983 KRYS, FOLD, NRIX, STOK 13F-HR 8/14/2024 000110465924089642
Q1 2024 77 2,724,553 KRYS, FOLD, IMNM, SRRK 13F-HR 5/15/2024 000110465924062013
Q4 2023 70 2,795,946 IMGN, KRYS, FOLD, SRRK 13F-HR 2/14/2024 000110465924023671
Q3 2023 68 2,101,757 IMGN, KRYS, FOLD, AKRO 13F-HR 11/14/2023 000110465923118113
Q2 2023 72 2,605,472 IMGN, KRYS, FOLD, REPL 13F-HR 8/14/2023 000110465923091352
Q1 2023 76 2,304,694 FOLD, KRYS, ISEE, DCPH 13F-HR 5/15/2023 000110465923060787
Q4 2022 69 2,444,691 FOLD, KRYS, AKRO, REPL 13F-HR 2/14/2023 000110465923021651
Q3 2022 70 2,578,101 FATE, FOLD, KRYS, ARGX 13F-HR 11/14/2022 000110465922118504
Q2 2022 71 2,618,868 FATE, FOLD, SGEN, ARGX 13F-HR 8/15/2022 000110465922091334
Q1 2022 70 3,203,503 FATE, FOLD, ARGX, LIVN 13F-HR 5/16/2022 000110465922061323
Q4 2021 71 4,398,640 FATE, FOLD, SNCE, ARGX 13F-HR 2/14/2022 000110465922023119
Q3 2021 75 5,733,591 FATE, ALLK, IGMS, ARGX 13F-HR 11/15/2021 000110465921139186
Q2 2021 86 6,757,873 FATE, IGMS, BEAM, ARGX 13F-HR 8/16/2021 000110465921106432
Q1 2021 86 7,099,728 FATE, ALLK, IGMS, ARGX 13F-HR 5/17/2021 000110465921068036
Q4 2020 87 8,258,586 FATE, FOLD, ALLK, BEAM 13F-HR 2/16/2021 000110465921023918
Q3 2020 81 5,447,026 FATE, FOLD, IMMU, ARGX 13F-HR 11/16/2020 000110465920125805
Q2 2020 80 5,416,834 FATE, FOLD, DCPH, ADCT 13F-HR 8/14/2020 000110465920095551
Q1 2020 69 3,566,983 FATE, FOLD, DCPH, BIIB 13F-HR 5/15/2020 000110465920062580
Q4 2019 64 4,180,807 DCPH, ALLK, FOLD, FATE 13F-HR 2/14/2020 000110465920021735
Q3 2019 74 2,988,202 ALLK, FOLD, FATE, DCPH 13F-HR 11/14/2019 000110465919064199
Q2 2019 81 3,525,347 ARRY, FOLD, FATE, ARGX 13F-HR 8/14/2019 000114420419040055
Q1 2019 82 3,417,745 ARRY, FOLD, FATE, ATRA RESTATEMENT 5/20/2019 000114420419027165
Q4 2018 78 2,486,494 ARRY, ATRA, FATE, XNCR RESTATEMENT 5/16/2019 000142573819000004
Q3 2018 83 3,250,425 ARRY, ATRA, FATE, RGNX RESTATEMENT 5/16/2019 000142573819000003
Q2 2018 81 2,943,811 ARRY, FOLD, ATRA, IMGN 13F-HR 8/14/2018 000142573818000026
Q1 2018 64 2,589,659 ARRY, ATRA, FOLD, IMGN 13F-HR 5/15/2018 000142573818000025
Q4 2017 1 6,604 LIFE NEW HOLDINGS 3/8/2018 000142573818000018
Q4 2017 69 2,293,585 ARRY, FOLD, PBYI, CLVSQ 13F-HR 2/14/2018 000142573818000017
Q3 2017 65 2,027,191 ARRY, FOLD, PBYI, SGEN 13F-HR 11/14/2017 000142573817000017
Q2 2017 64 1,619,615 ARRY, FOLD, PEN, PBYI 13F-HR 8/15/2017 000142573817000014
Q1 2017 60 1,540,736 ARRY, PEN, FOLD, PBYI 13F-HR 5/15/2017 000142573817000012
Q4 2016 50 1,160,076 ARRY, SGEN, CLVSQ, PEN 13F-HR 2/14/2017 000142573817000010
Q3 2016 51 1,257,292 ARRY, SGEN, FOLD, CLVSQ 13F-HR 11/15/2016 000142573816000040
Q2 2016 54 1,046,928 ARRY, FOLD, MDVN, SGEN 13F-HR 8/16/2016 000142573816000039
Q1 2016 47 965,552 FOLD, MDVN, CLVSQ, PEN 13F-HR 5/16/2016 000142573816000037
Q4 2015 57 1,295,666 FOLD, MDVN, PEN, ARRY 13F-HR 2/16/2016 000142573816000035
Q3 2015 58 1,319,989 FOLD, CLVSQ, ARRY, MDVN RESTATEMENT 11/17/2015 000142573815000021
Q2 2015 55 1,220,168 ARRY, FOLD, VRX, CLVSQ 13F-HR 8/14/2015 000142573815000017
Q1 2015 54 1,113,749 ARRY, CLVSQ, FOLD, VRX 13F-HR 5/18/2015 000142573815000014
Q4 2014 54 918,447 FOLD, ARRY, VRX, CMRX 13F-HR 2/18/2015 000159754915000003
Q3 2014 54 812,009 ISHARES TR puts, VRX, ACT, CLVSQ 13F-HR 11/14/2014 000132130014000007
Q2 2014 48 822,448 ACT, MDT, ARRY, UHS 13F-HR 8/15/2014 000142573814000003
Q1 2014 55 837,581 ACT, HCA, A, VRX RESTATEMENT 8/19/2014 000142573814000004
Q4 2013 56 796,219 GILD, CLVSQ, ZBH, CELG 13F-HR 2/14/2014 000142573814000001
Additional filings from Redmile Group, LLC that have since been restated

13D and 13G Filings

All 13D and 13G filings

Each security where the latest filing since 12/18/2024 is a 13D, newest first.

Issuer % of Class Filed
Fate Therapeutics, Inc. 13D/A
FATE · 31189P102
15.0% 11/9/2026
Event 11/5/2026
Atara Biotherapeutics, Inc. 13D/A
ATRA · 046513206
9.9% 7/24/2026
Event 7/22/2026
Shattuck Labs, Inc. 13D/A
STTK · 82024L103
9.9% 7/17/2026
Event 7/15/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Absci Corporation 13D/A
ABSI · 00091E109
4.9% 4/14/2026
Event 4/10/2026
IGM Biosciences, Inc. 13D/A
IGMS · 449585108
0% 8/15/2025
Event 8/14/2025

19 other securities where the latest filing is a 13G, the newest filed 11/16/2026. View all